<?xml version="1.0" encoding="us-ascii"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mater.</journal-id>
<journal-title>Frontiers in Materials</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mater.</abbrev-journal-title>
<issn pub-type="epub">2296-8016</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1409310</article-id>
<article-id pub-id-type="doi">10.3389/fmats.2024.1409310</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Materials</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Formulation and structural insight of biocompatible microemulsion for enhanced release profile of anticancer methotrexate</article-title>
<alt-title alt-title-type="left-running-head">Siddique et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmats.2024.1409310">10.3389/fmats.2024.1409310</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Siddique</surname>
<given-names>Muhammad Yasir</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2617278/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zafar</surname>
<given-names>Sehrish</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2617603/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rizwan</surname>
<given-names>Linta</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saleem</surname>
<given-names>Muhammad Atif</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2656603/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haider</surname>
<given-names>Sajjad</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2124877/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Azeem</surname>
<given-names>Waqar</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alam</surname>
<given-names>Kamran</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2618383/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iqbal</surname>
<given-names>Yasir</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2704963/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sumrra</surname>
<given-names>Sajjad Hussain</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1863496/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Nazar</surname>
<given-names>Muhammad Faizan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1857178/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Chemistry</institution>, <institution>University of Gujrat</institution>, <addr-line>Gujrat</addr-line>, <country>Pakistan</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Chemistry</institution>, <institution>University of Education</institution>, <addr-line>Lahore</addr-line>, <country>Pakistan</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Chemical Engineering Department</institution>, <institution>College of Engineering</institution>, <institution>King Saud University</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Lahore Chemical &#x26; Pharmaceutical Works (Private) Limited</institution>, <addr-line>Lahore</addr-line>, <country>Pakistan</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Chemical Engineering Materials Environment Sapienza University of Rome</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Chemistry</institution>, <institution>Government College University</institution>, <addr-line>Faisalabad</addr-line>, <country>Pakistan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/93430/overview">Miloslav Peka&#x159;</ext-link>, Brno University of Technology, Czechia</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1064147/overview">Nemany A. N. Hanafy</ext-link>, Kafrelsheikh University, Egypt</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/840702/overview">Ajaya Bhattarai</ext-link>, Tribhuvan University, Nepal</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Muhammad Faizan Nazar, <email>faizan.nazar@ue.edu.pk</email>, <email>faizan_qau@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>11</volume>
<elocation-id>1409310</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Siddique, Zafar, Rizwan, Saleem, Haider, Azeem, Alam, Iqbal, Sumrra and Nazar.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Siddique, Zafar, Rizwan, Saleem, Haider, Azeem, Alam, Iqbal, Sumrra and Nazar</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Microemulsions (&#x3bc;Es) are particularly suitable systems for the efficient delivery of anticancer drugs due to their thermodynamic stability, structural flexibility, and patient-friendly chemotherapies. Moreover, &#x3bc;E formulations can efficiently encapsulate the anticancer drugs and deliver them to the desired location. Herein, three new Tween-60-based &#xb5;E formulations were developed to enhance the dissolution profile of anticancer methotrexate (MTX). For this, &#x3bc;E formulations using an appropriate ratio of castor oil (&#x223c;9%), water (&#x223c;11%), and Tween-60 (&#x223c;40%) were used, while ethanol, 2-propanol, and 1-butanol were selected as co-surfactants for each formulation, respectively. Preliminarily, the phase compatibility of the &#x3bc;E ingredients, the average &#x3bc;E region, and the structural transformation in the microstructure of &#x3bc;E were delineated by mapping the pseudoternary phase diagram, as well as electrical conductivity, viscosity, and optical microscopic measurements. The size distribution profile of the as-formulated &#x3bc;Es analyzed by dynamic light scattering (DLS) revealed the fine monomodal assembly of MTX-&#x3bc;E nanodroplets (&#x223c;65 nm), which remained stable over a half year of storage. FTIR analysis showed good compatibility of MTX with &#x3bc;E ingredients with no apparent chemical interaction, while fluorescence measurements endorsed the acquisition of MTX in nonpolar microenvironments. Furthermore, an enhanced dissolution rate (&#x3e;98% &#xb1; 1.5%, <italic>p</italic> &#x2264; 0.001) and superior bioavailability of the lyophilized non-aggregated methotrexate nanoparticles (MTX-NPs) were achieved, making them a suitable formulation for oral administration.</p>
</abstract>
<kwd-group>
<kwd>microemulsion</kwd>
<kwd>microenvironment</kwd>
<kwd>microstructure</kwd>
<kwd>nanodroplets</kwd>
<kwd>bioavailability</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Colloidal Materials and Interfaces</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Due to the uncontrolled growth and widespread distribution of abnormal cells throughout the body, cancer remains a major global public health challenge. These abnormal cells can proliferate uncontrollably and form large abnormal cell clusters called tumors that disrupt normal physiological functions (<xref ref-type="bibr" rid="B19">Hegde and Chen, 2020</xref>). In addition, malignant cells have the ability to invade surrounding tissue and migrate to distant areas of the body via the bloodstream or lymphatics, a process called metastasis (<xref ref-type="bibr" rid="B6">Barrios, 2022</xref>). The most common types of cancer include lung, prostate, colon, and breast cancer. According to recent population health projections, the estimated global incidence of cancer diagnoses is expected to continue to increase in the coming decades, with new cases discovered reaching over 20 million annually by 2025, increasing cancer incidence (<xref ref-type="bibr" rid="B60">Zugazagoitia et al., 2016</xref>; <xref ref-type="bibr" rid="B17">Ginsburg et al., 2017</xref>).</p>
<p>Methotrexate (MTX) is one of the main drugs used for a range of cancer treatments. It is commonly used to treat psoriasis. As an early-stage chemotherapy agent, MTX is widely used in the treatment of breast, lung, and head and neck cancers. Interestingly, research also suggests that MTX may reduce the risk of cardiovascular complications. The drug is similarly used for rheumatoid arthritis, which is likely achieved by increasing adenosine levels in the body. While stopping folate synthesis risks exacerbating oxidative damage, MTX itself works to eliminate harmful substances and reduce unwarranted inflammation (<xref ref-type="bibr" rid="B38">O Dell, 1997</xref>). The administration of high-dose MTX results in bone marrow suppression by impeding the replication of healthy cells and causing gastrointestinal inflammation. Therefore, to avoid or mitigate these negative effects of MTX, it is essential to find an ideal carrier or delivery approach that allows the targeted delivery of optimal MTX quantities. One challenge is that MTX has poor solubility in fat compositions, complicating delivery efforts (<xref ref-type="bibr" rid="B29">Moshikur et al., 2021</xref>). The use of unique dispersions has been shown to be beneficial in improving MTX absorption by the body and reducing unwanted side effects (<xref ref-type="bibr" rid="B43">Rahdar et al., 2020</xref>; <xref ref-type="bibr" rid="B9">Changez et al., 2024</xref>). Regarding formulation, scientists strive to develop micro- and nanocarriers for various pharmaceutical compounds, and microemulsions (&#xb5;Es) are emerging as effective drug carriers (<xref ref-type="bibr" rid="B47">Ray et al., 2015</xref>; <xref ref-type="bibr" rid="B56">Ullah et al., 2022</xref>). The key advantages of &#xb5;Es include their thermodynamic stability, low viscosity, and ability to solubilize both hydrophilic and hydrophobic molecules. Their application promises controlled release and delivery of MTX for improved therapeutic outcomes (<xref ref-type="bibr" rid="B26">Mahdavinia et al., 2017</xref>; <xref ref-type="bibr" rid="B35">Nazar et al., 2017</xref>; <xref ref-type="bibr" rid="B16">Ghazy and Hanafy, 2024</xref>).</p>
<p>&#xb5;Es are stable dispersions of water, oil, and surfactants that maintain clarity and optical uniformity. Surfactants and co-surfactants provide these systems with increased surface activity, reduced surface tension, and favorable viscosity properties (<xref ref-type="bibr" rid="B52">Siddique et al., 2021a</xref>; <xref ref-type="bibr" rid="B48">Saleem et al., 2023</xref>). There are three main types: oil-in-water (O/W) &#x3bc;Es, with oil droplets dispersed in a continuous aqueous phase, used for applications requiring smaller amounts of oil; water-in-oil (w/o) &#xb5;Es, consisting of water droplets dispersed in a continuous oil phase and widely used for high-oil concentration requirements; and bicontinuous &#xb5;Es, where both the oil and water phases exhibit continuity and interconnectivity (<xref ref-type="bibr" rid="B31">Nazar et al., 2011a</xref>; <xref ref-type="bibr" rid="B4">Azfaralariff et al., 2020</xref>). Due to their ability to effectively solubilize hydrophobic compounds such as MTX, &#xb5;Es improve bioavailability (<xref ref-type="bibr" rid="B23">KIZIBASH et al., 2011</xref>). Furthermore, the tiny droplet size within &#xb5;Es enhances drug permeation and limits loss through first-pass metabolism, presenting great potential for targeted drug delivery (<xref ref-type="bibr" rid="B3">Amarji et al., 2016</xref>; <xref ref-type="bibr" rid="B12">Essa et al., 2020</xref>; <xref ref-type="bibr" rid="B55">Sultan Rana et al., 2023</xref>).</p>
<p>In the current study, three new &#xb5;E systems were developed, consisting of castor oil as an oil phase, Tween-60 as a surfactant, and water as an aqueous phase. Ethanol, 2-propanol, and 1-butanol aided as co-surfactants in &#xb5;E-A, &#xb5;E-B, and &#xb5;E-C, respectively, to improve the dissolution profile of anticancer MTX. The optimal &#xb5;E systems contain 3.5 wt% methotrexate at pH 6.5, 4.8 wt% at pH 6.9, and 4.2 wt% at pH 6.3 for &#xb5;E-A, &#xb5;E-B, and &#xb5;E-C, respectively. These loaded &#xb5;Es were found to be more effective than other designs, highlighting their utility for the improved delivery of MTX. Moreover, an enhanced dissolution rate (&#x3e;98%) and superior bioavailability of the lyophilized non-aggregated methotrexate nanoparticles (MTX-NPs) were achieved, making them a suitable formulation for oral administration (<xref ref-type="bibr" rid="B36">Nazar et al., 2021</xref>).</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Materials and chemicals</title>
<p>Absolute ethanol (&#x2265;99.8%), 2-propanol (99.99%), 1-butanol (99.99%), castor oil, and Tween-60<sup>&#xae;</sup> (99.99%) were purchased from Sigma-Aldrich. Methotrexate (working standards) was provided by Lahore Chemical &#x26; Pharmaceutical Works (Private) Limited, Pakistan (the molecular structures of MTX and Tween 60 are shown in <xref ref-type="sec" rid="s10">Supplementary Figures S1, S2</xref> in <xref ref-type="sec" rid="s10">Supplementary Material</xref>, respectively). Deionized and double-distilled water (conductivity &#x2264;1 &#x3bc;s/cm and viscosity 0.01 poise) was used for dilution and other experimental purposes.</p>
</sec>
<sec id="s2-2">
<title>Preparation of the o/w &#x3bc;E</title>
<p>Three new &#x3bc;E formulations were prepared using Tween-60 (HLB &#x3d; 14.9), ethanol, 2-propanol, and 1-butanol at a constant ratio (1:1). To obtain a translucent &#x3bc;E, a surfactant mixture (S<sub>mix</sub>) was placed in an ultrasonicator, followed by the addition of an appropriate amount of castor oil and further dilution with water using the titration method. The pseudoternary phase diagram was mapped using Tween-60 as the surfactant, castor oil as oil, and water as the aqueous phase (<xref ref-type="fig" rid="F1">Figure 1</xref>). Ethanol, 2-propanol, and 1-butanol were used as co-surfactants in the preparation of &#x3bc;E-A, &#x3bc;E-B, and &#x3bc;E-C, respectively. The final composition of the optimal &#x3bc;E-A consists of Tween-60 (40%), ethanol (40%), castor oil (9%), and water (11%); the optimal &#x3bc;E-B composition consists of Tween-60 (38%), 2-propanol (38%), castor oil (9%), and water (15%); and the optimal &#x3bc;E-C composition consists of Tween-60 (41%), 1-butanol (41%), castor oil (8%), and water (10%). The morphological transformation of all systems from an oil-rich (w/o) system to a water-rich (o/w) system was accessed at a constant oil-to-surfactant ratio by selecting a water dilution line AB highlighted in the pseudoternary phase diagram.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Pseudoternary phase diagram showing the one-phase region &#xb5;E (purple-shaded) of ethanol/Tween-60/castor oil/water as &#x3bc;E-A, 2-propanol/Tween-60/castor oil/water (olive-shaded) as &#x3bc;E-B, and 1-butanol/Tween-60/castor oil/water (blue-shaded) as &#x3bc;E-C. The red line represents the dilution line selected for further investigations. The highlighted green mark on the dilution line represents the optimal &#xb5;E composition.</p>
</caption>
<graphic xlink:href="fmats-11-1409310-g001.tif"/>
</fig>
</sec>
<sec id="s2-3">
<title>Incorporation of MTX in the &#x3bc;E and preparation of MTX nanoparticles</title>
<p>Under continuous stirring, the maximum amount of MTX was loaded into the optimal systems as follows: 3.5 wt.% at pH 6.5, 4.8 wt.% at pH 6.9, and 4.2 wt.% at pH 6.3 for &#x3bc;E-A, &#x3bc;E-B, and &#x3bc;E-C, respectively. To maintain the temperature at 25&#xb0;C &#xb1; 0.5&#xb0;C, a Lauda M20 thermostatic water bath was used. All three &#x3bc;E systems (MTX-free and MTX-loaded) were stable and remained clear for 6&#xb0;months. A rotary evaporator was used to obtain the MTX NPs. All &#x3bc;E formulations were freeze-dried, placing the colloidal solution in a freeze dryer (model: Alpha 1-2 LD Plus; Christ) to remove all water and organic substances and obtain fine and dried MTX nanopowder. The loading efficiency percentage (LE%) and entrapment efficiency percentage (EE%) of MTX were computed using the following formula:<disp-formula id="e1">
<mml:math id="m1">
<mml:mrow>
<mml:mi>L</mml:mi>
<mml:mi>E</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>t</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>M</mml:mi>
<mml:mi>T</mml:mi>
<mml:mi>X</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>t</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>M</mml:mi>
<mml:mi>T</mml:mi>
<mml:mi>X</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>s</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>t</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>f</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>
<disp-formula id="e2">
<mml:math id="m2">
<mml:mrow>
<mml:mi>E</mml:mi>
<mml:mi>E</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>t</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>M</mml:mi>
<mml:mi>T</mml:mi>
<mml:mi>X</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>t</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>M</mml:mi>
<mml:mtext>TX</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>l</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>q</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>t</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>M</mml:mi>
<mml:mi>X</mml:mi>
<mml:mi>D</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>
</p>
</sec>
</sec>
<sec id="s11">
<title>Characterization of the microemulsion</title>
<sec id="s11-1">
<title>Physiochemical properties, stability, and optical microscopy study</title>
<p>The stability and homogeneity of all MTX-free and MTX-loaded &#x3bc;E formulations were checked by centrifugation of the samples for 15 min at 3,000 rpm using a Hermle Z-200A Centrifuge (Germany). The biological microscope (LABOMED FLR Lx 400, Jenoptik, Germany) had a magnification of 4&#xd7;/10&#xd7;/40&#xd7;/100&#xd7; and was used to manifest any type of structural transition occurring in the structure of MTX-free &#x3bc;E systems.</p>
</sec>
<sec id="s11-2">
<title>Electrical conductivity and viscosity measurements</title>
<p>The phase changes from w/o to o/w via a bicontinuous phase within the MTX-free &#x3bc;E were assessed using electrical conductivity measurements. A conductometer (ADWA AD3000, Hungary) was used to measure the electric conductivity (&#x3c3;), whereas viscosity (&#x19e;) was measured using a calibrated Brookfield viscometer (LVDV-2T, United States) at 25&#xba;C &#xb1; 1&#xb0;C with 150 rpm by flushing and washing the viscosity at each measurement.</p>
</sec>
<sec id="s11-3">
<title>Size distribution and morphological analysis</title>
<p>The average droplet size and zeta potential of MTX-free and MTX-loaded &#x3bc;E systems were determined at room temperature using a Zetasizer (Malvern, Nano ZSP, United Kingdom). Morphological analyses were conducted to explore the internal structure of both MTX-free and MTX-loaded &#x3bc;Es. These investigations were performed using a JEOL 2100 high-resolution transmission electron microscope (HRTEM, Japan), equipped with a LaB6 electron gun operating at 200 KV. Samples of the MTX-free and MTX-loaded &#x3bc;E were carefully positioned onto copper grids and subsequently air-dried to prepare them for observation under the microscope.</p>
</sec>
<sec id="s11-4">
<title>Spectroscopic measurements</title>
<p>FTIR spectra were recorded of pure MTX, MTX-free, and MTX-loaded &#x3bc;E systems at a resolution of 2 cm<sup>-1</sup> within the range of 500&#x2013;4,000 cm<sup>-1</sup> using a Bruker FTIR (Alpha Series, Germany). Meanwhile, a spectrofluorophotometer (Shimadzu RF-6000, Japan) was used to measure steady-state fluorescence. A range of 300&#x2013;600 nm was used to record the fluorescence spectra of MTX. These spectra were recorded in the aqueous phase, oil phase, and all S<sub>mix</sub> (1:1) and optimal &#x3bc;E systems.</p>
</sec>
<sec id="s11-5">
<title>Dissolution release study</title>
<p>The dissolution rate of MTX-NPs was examined using USP apparatus I (Basket) at 50 rpm for 30 min in 900 mL of the dissolution medium. The temperature was maintained at 37&#xb0;C &#xb1; 0.5&#xb0;C. For the dissolution test, the PT-DT70 instrument was used, and the absorbance at 306 &#xb1; 2 nm was measured using a UV&#x2013;visible spectrophotometer (Shimadzu UV-1800, Japan). After a set period of 45 min, the samples were removed, and the extracted liquid was replaced with the dissolution medium. The sample was filtered using a 0.45-&#xb5;m filter paper. Each test was performed in triplicate.</p>
<p>A comparative dissolution profile of MTX-NPs and methotrexate&#x2013;commercial formulation (MTX-CF) was also studied at buffer pH 1.2, buffer pH 4.5, and buffer pH 6.8. Twelve units (equivalent to the same active substance weight) of both types of products were taken. The dissolution time was 60 min, and the same conditions were applied as mentioned above for the study. The sample was drawn at 5, 10, 15, 20, 30, 45, and 60 min. The sample was drawn and filtered using a 0.45-&#xb5;m filter paper. The same volume was added to the dissolution as drawn. The UV&#x2013;visible spectrophotometer (Shimadzu UV-1800) was used to measure the sample and standard solution at 306 &#xb1; 2 nm.</p>
<p>MTX-NP-&#x3bc;E-A, MTX-NP-&#x3bc;E-B, and MTX-NP-&#x3bc;E-C were stored at 15&#xb0;C and elevated temperatures (40&#xb0;C) for more than 6 months. No change in physical form was observed for all three formulations. The stability data show that all three formulations are stable and can be used commercially.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and discussions</title>
<sec id="s3-1">
<title>Phase studies and physiochemical behavior</title>
<p>A ternary phase diagram is used to help study the phase behavior and determine the ideal circumstances for the generation of &#x3bc;Es by checking the compatibility of oil, water, and the surfactant (<xref ref-type="bibr" rid="B45">Rahman et al., 2017</xref>). It also helps determine the correlation between the phase behavior of the excipients of &#x3bc;Es and drug molecules (<xref ref-type="bibr" rid="B28">Mitchell and Ninham, 1981</xref>). The water dilution method was used to investigate the behavior of each phase; it is a quick, precise, and economical procedure (<xref ref-type="bibr" rid="B40">Pal et al., 2017</xref>). Optimal &#x3bc;E-A comprises Tween-60 (40%), ethanol (40%), castor oil (9%), and water (11%); optimal &#x3bc;E-B comprises Tween-60 (38%), 2-propanol (38%), castor oil (9%), and water (15%); and optimal &#x3bc;E-C comprises Tween-60 (41%), 1-butanol (41%), castor oil (8%), and water (10%), respectively. The shaded area in <xref ref-type="fig" rid="F1">Figure 1</xref> shows the &#x3bc;E region, and the dilution line is indicated by red lines in that &#x3bc;E region. The highlighted mark on the dilution line signifies the optimal &#x3bc;E that is used for further investigation and characterization (<xref ref-type="bibr" rid="B49">Saleem et al., 2018</xref>). Water-rich quantity shows that the optimal &#x3bc;E is w/o &#x3bc;E. <xref ref-type="fig" rid="F1">Figure 1</xref> shows the differences in the &#x3bc;E region, which are attributed to the varying co-surfactants used in the three systems (<xref ref-type="bibr" rid="B52">Siddique et al., 2021a</xref>).</p>
<p>The compatibility of oil with the co-surfactant and surfactant chain length plays a crucial role in determining the formation of &#xb5;E structures (<xref ref-type="bibr" rid="B24">Lawrence and Rees, 2012</xref>). The different physiochemical properties of the &#x3bc;E systems are presented in <xref ref-type="table" rid="T1">Table 1</xref>. However, the microstructural transitions in the structure of the &#x3bc;E system cannot be evaluated using the ternary phase diagram. Therefore, the transitions in the one-phase region of the &#xb5;E system are explored by conductivity (&#x3c3;), viscosity (&#x3b7;), and optical microscopic analysis as a weight fraction of the aqueous component (&#x3a6;<sub>w</sub>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Physical parameters of optimal &#x3bc;Es.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Physical property</th>
<th colspan="2" align="center">&#xb5;E-A: castor oil, water, Tween-60, and ethanol</th>
<th colspan="2" align="center">&#xb5;E-B: castor oil, water, Tween-60, and 2-propanol</th>
<th colspan="2" align="center">&#xb5;E-C: castor oil, water, Tween-60, and 1-butanol</th>
</tr>
<tr>
<th align="center">MTX-free &#x3bc;E</th>
<th align="center">MTX-loaded &#x3bc;E</th>
<th align="center">MTX-free &#x3bc;E</th>
<th align="center">MTX-loaded &#x3bc;E</th>
<th align="center">MTX-free &#x3bc;E</th>
<th align="center">MTX-loaded &#x3bc;E</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Physical form</td>
<td colspan="6" align="center">Pale-yellow clear liquid</td>
</tr>
<tr>
<td align="left">pH</td>
<td align="center">6.3 &#xb1; 0.3</td>
<td align="center">6.5 &#xb1; 0.1</td>
<td align="center">6.4 &#xb1; 0.4</td>
<td align="center">6.9 &#xb1; 0.2</td>
<td align="center">6.1 &#xb1; 0.3</td>
<td align="center">6.3 &#xb1; 0.2</td>
</tr>
<tr>
<td align="left">Viscosity (cP)</td>
<td align="center">24.5 &#xb1; 2.5</td>
<td align="center">27.3 &#xb1; 3.0</td>
<td align="center">26.5 &#xb1; 1.5</td>
<td align="center">29.3 &#xb1; 2.5</td>
<td align="center">31.5 &#xb1; 3.0</td>
<td align="center">33.3 &#xb1; 4.0</td>
</tr>
<tr>
<td align="left">Particle size DLS (d.nm)</td>
<td align="center">41.5 &#xb1; 1.5</td>
<td align="center">62.5 &#xb1; 2.0</td>
<td align="center">55.0 &#xb1; 2.5</td>
<td align="center">70.5 &#xb1; 3.5</td>
<td align="center">57.5 &#xb1; 1.5</td>
<td align="center">72.0 &#xb1; 3.0</td>
</tr>
<tr>
<td align="left">Diffusion constant (cm<sup>2</sup>/s)</td>
<td align="center">1.41 &#xd7; 10<sup>&#x2212;9</sup>
</td>
<td align="center">8.41 &#xd7; 10<sup>&#x2212;10</sup>
</td>
<td align="center">9.8 &#xd7; 10<sup>&#x2212;10</sup>
</td>
<td align="center">6.95 &#xd7; 10<sup>&#x2212;10</sup>
</td>
<td align="center">7.93 &#xd7; 10<sup>&#x2212;10</sup>
</td>
<td align="center">6.0 &#xd7; 10<sup>&#x2212;10</sup>
</td>
</tr>
<tr>
<td align="left">&#x3b6;-potential (mV)</td>
<td align="center">&#x2212;30.5 &#xb1; 0.5</td>
<td align="center">&#x2212;36.9 &#xb1; 1.1</td>
<td align="center">&#x2212;26.5 &#xb1; 1.5</td>
<td align="center">&#x2212;28.6 &#xb1; 2.0</td>
<td align="center">&#x2212;32.4 &#xb1; 0.3</td>
<td align="center">&#x2212;36.8 &#xb1; 0.5</td>
</tr>
<tr>
<td align="left">Stability</td>
<td colspan="6" align="center">6 months of storage</td>
</tr>
<tr>
<td align="left">FTIR</td>
<td colspan="6" align="center">MTX has good compatibility with &#xb5;E excipients</td>
</tr>
<tr>
<td align="left">Fluorescence</td>
<td colspan="6" align="center">MTX encapsulated in the hydrophobic microenvironment</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-2">
<title>Electrical conductivity measurements</title>
<p>Electrical conductivity is a useful technique for evaluating the structural transition and forecasting a conductive network channel (bicontinuous &#x3bc;E) in &#xb5;Es. The conductance is measured along the dilution line AB by constantly adding water to the oil, surfactant, and co-surfactant mixture (<xref ref-type="bibr" rid="B1">Acosta et al., 1996</xref>; <xref ref-type="bibr" rid="B58">Yadav et al., 2018</xref>). As the water was added, a change in the electrical conductance of the mixture occurred, as shown in <xref ref-type="fig" rid="F2">Figure 2</xref>, which displays the plot of &#x3c3; and its first derivative (d&#x3c3;/d&#x3a6;) <italic>versus</italic> &#x3a6;<sub>w</sub> for each &#xb5;E system. An abrupt change occurred when the phase transition occurred. The phase transition from a w/o to o/w &#xb5;E occurred, although the bicontinuous phase is determined by the conductivity (&#x3c3;) of the water component (weight fraction) &#x3a6;<sub>w</sub> (<xref ref-type="bibr" rid="B21">Kahlweit et al., 1993</xref>; <xref ref-type="bibr" rid="B39">Olivieri et al., 2003</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Discrepancy in the electrical conductivity (&#x3c3;) and the first derivative of the electric conductivity (d&#x3c3;/d&#x3a6;) with &#x3a6;<sub>w</sub> (wt%) of &#xb5;E-A, &#xb5;E-B, and &#xb5;E-C.</p>
</caption>
<graphic xlink:href="fmats-11-1409310-g002.tif"/>
</fig>
<p>For &#xb5;E-A, <xref ref-type="fig" rid="F2">Figure 2 shows that</xref> the &#x3a6;<sub>w</sub> value is below &#x223c;8%, and the bicontinuous region of &#xb5;E-A begins at &#x223c; 9% &#x3a6;<sub>w</sub>, called the percolation threshold (&#x3a6;<sub>p</sub>), below the slight increase observed in the &#x3a6;<sub>w</sub> value (w/o &#xb5;E). At a value of 16% &#x3a6;<sub>w</sub>, sudden changes occurred, which indicated that &#x3c3; decreased due to the increase in water content. The increase in water content leads to the development of o/w, which leads to the phase transition of &#x3a6;<sub>b</sub>. With the increase in the value of &#x3a6;<sub>w</sub>, the change in the first derivative (d&#x3c3;/d&#x3c6;) also further helps determine the phase transition in the &#xb5;E domain (<xref ref-type="bibr" rid="B13">Formariz et al., 2008</xref>; <xref ref-type="bibr" rid="B40">Pal et al., 2017</xref>).</p>
<p>For &#xb5;E-B, &#x3a6;<sub>w</sub> slightly increases until the critical &#x3a6;<sub>w</sub> value is 4.5%. The bicontinuous region starts at 5% of the percolation threshold (&#x3a6;<sub>p</sub>). At this value, &#x3a6;<sub>p</sub> w/o &#xb5;E exists and is higher than the &#x3a6;<sub>p</sub> value (&#x3a6;<sub>w</sub> &#x3e; 4.4%). &#x3c3; increases until &#x3a6;<sub>b</sub> (&#x3a6;<sub>w</sub> &#x223c;8.6%) is formed. After &#x3a6;<sub>b</sub>, the sudden decrease in the &#x3c3; value corresponds to an increase in the water ratio, thereby forming the o/w &#xb5;E (<xref ref-type="bibr" rid="B15">Gaudana et al., 2010</xref>). For &#xb5;E-C, the &#x3a6;p value starts at 6.0% &#x3a6;<sub>w</sub>, which is slightly higher than the &#x3a6;<sub>w</sub> value (w/o &#xb5;E). The changes occur at the 14.5% &#x3a6;<sub>w</sub> value, which indicates that &#x3c3; decreases as the water content increases. The increase in water content causes the development of the o/w &#xb5;E, which leads to the phase transition of &#x3c6;b</p>
<sec id="s3-2-1">
<title>Viscosity measurements</title>
<p>Viscosity measurement is a commonly used approach to observe the occurrence of phase transitions in &#xb5;Es since it depends on the droplet size (<xref ref-type="bibr" rid="B57">&#xdc;st&#xfc;nda&#x11f;-Okur et al., 2014</xref>). Along the dilution line AB, for all three &#xb5;E systems, viscosity (&#x3b7;) and its first derivative (d&#x3b7;/d&#x3a6;) were mapped as a function of &#x3a6;<sub>w</sub>, as shown in <xref ref-type="fig" rid="F3">Figure 3</xref>. The change in the viscosity trend followed the same pattern as the conductivity. The change in water content along the dilution line resulted in a viscosity change. It was observed that a steady increase in viscosity with increasing weight fraction (&#x3a6;<sub>w</sub>) of the aqueous component for every formulation occurred, which could be beneficial for controlling the slow diffusion of MTX at high dilutions (<xref ref-type="bibr" rid="B1">Acosta et al., 1996</xref>; <xref ref-type="bibr" rid="B5">Baptista and Tran, 1997</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Variation in viscosity (&#x3b7;) and its first derivative (d&#x3b7;/d&#x3a6;) with water content as a function of &#x3a6;<sub>w</sub> (wt%) of optimal &#xb5;E-A, &#xb5;E-B, and &#xb5;E-C.</p>
</caption>
<graphic xlink:href="fmats-11-1409310-g003.tif"/>
</fig>
<p>By increasing the plots between (d&#x3b7;/d&#x3a6;) and &#x3a6;<sub>w</sub>, &#x3a6;p and phase transition of &#xb5;Es can be determined, as shown in <xref ref-type="fig" rid="F2">Figure 2</xref>. The results of &#xb5;E-A, &#xb5;E-B, and &#xb5;E-C of the &#x3a6;<sub>p</sub> computed (d&#x3b7;/d&#x3a6;) and &#x3a6;<sub>w</sub> assumed showed that there is a w/o &#xb5;E up to 10%, from 10% to 20% the o/w phase of the transition, and after 20%, there is an o/w &#xb5;E (<xref ref-type="bibr" rid="B27">Malik et al., 2006</xref>).</p>
</sec>
</sec>
<sec id="s3-3">
<title>Microscopic studies</title>
<p>The biological microscope was used to examine the microstructural transitions in &#xb5;E systems via the bicontinuous phase, which determines the process of microstructure modification of &#xb5;E (<xref ref-type="bibr" rid="B33">Nazar et al., 2020</xref>). <xref ref-type="fig" rid="F4">Figures 4A&#x2013;C</xref> show three anticipated phase transitions of &#xb5;E-A; w/o &#xb5;E, bicontinuous networks, o/w &#xb5;E, and the proposed microstructure changes are shown in <xref ref-type="fig" rid="F4">Figure 4,</xref> which shows the microstructure transformation of &#xb5;Es with increasing concentration of the aqueous phase (<xref ref-type="bibr" rid="B42">Paria and Khilar, 2004</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Microscopic images of &#xb5;E-A; <bold>(A)</bold> w/o &#xb5;E, <bold>(B)</bold> bicontinous &#xb5;E, <bold>(C)</bold> o/w &#xb5;E; along with the proposed microstructure variations in the &#xb5;E.</p>
</caption>
<graphic xlink:href="fmats-11-1409310-g004.tif"/>
</fig>
<p>
<xref ref-type="fig" rid="F4">Figure 4A</xref> shows a w/o &#xb5;E with dispersed water droplets in the oil phase, while the o/w &#xb5;E revealed that the oil droplets were present in the continuous aqueous phase (<xref ref-type="fig" rid="F4">Figure 4C</xref>), and the bicontinuous &#xb5;E showed a network of spherical droplets creating bicontinuous channels (<xref ref-type="fig" rid="F4">Figure 4B</xref>). These results were also consistent with earlier studies (<xref ref-type="bibr" rid="B37">Nazar et al., 2018</xref>). The hydrophilic&#x2013;lipophilic balance (HLB) between the surfactant and co-surfactant had an impact on the microstructures of the &#xb5;E systems. o/w systems were produced by a lipophilic-leaning HLB, whereas w/o systems were produced by a hydrophilic-leaning HLB. When neither oil nor water droplets predominated, a bicontinuous &#xb5;E appeared, suggesting percolation behavior (<xref ref-type="bibr" rid="B22">Khan et al., 2016</xref>; <xref ref-type="bibr" rid="B44">Rahman et al., 2016</xref>). The microstructure transformation of &#xb5;E-B and &#xb5;E-C with increasing concentrations of the aqueous phase obtained from an optical microscope is shown in <xref ref-type="sec" rid="s10">Supplementary Material</xref> (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>).</p>
<p>The enhanced solubility of MTX in each optimized &#x3bc;E formulation is achieved, i.e., 3.5 wt% at pH 6.5, 4.8 wt% at pH 6.9, and 4.2 wt% at pH 6.3 in &#x3bc;E-A, &#x3bc;E-B, and &#x3bc;E-C, respectively. Furthermore, high EE% and excessive LE% are obtained for each formulation. The quantitative EE% and LE% are 94.22% &#xb1; 0.48% and 22.50% &#xb1; 0.48 for &#x3bc;E-A, 86.78% &#xb1; 0.92% and 17.75% &#xb1; 0.48 for &#x3bc;E-B, and 82.45% &#xb1; 1.15% and 15.95% &#xb1; 0.48 for &#x3bc;E-C, respectively.</p>
</sec>
<sec id="s3-4">
<title>Size distribution and zeta potential measurements</title>
<p>The evaluation of physical stability is a key factor in the preparation of &#xb5;E systems. Particles having a smaller size exhibit a higher surface area and can easily permeate with fast release (<xref ref-type="bibr" rid="B54">Siddique et al., 2024</xref>). The particle size distribution of MTX-free &#xb5;E-A and MTX-loaded &#xb5;E-A was computed, as shown in <xref ref-type="fig" rid="F5">Figure 5A</xref>. The average size of MTX-free &#xb5;E-A was &#x223c;42 nm, with a polydispersity index (PDI) of 0.112. Likewise, the average size of MTX-loaded &#xb5;E-A was &#x223c;62.5 nm, and the PDI was 0.194. The DLS results showed an increase in size upon the loading of MTX in the optimal &#xb5;E, which confirmed the encapsulation of MTX (<xref ref-type="bibr" rid="B59">Zafar et al., 2024</xref>). MTX-loaded &#xb5;E-A exhibited an increase in size due to the loading of MTX (<xref ref-type="bibr" rid="B45">Rahman et al., 2017</xref>; <xref ref-type="bibr" rid="B52">Siddique et al., 2021a</xref>). The small size of droplets provides higher mobility, enhanced surface area for encapsulation, and enhanced dissolution and maximum release of the drug. Moreover, the larger size of the &#xb5;E systems provides less mobility, which leads to slow drug release (<xref ref-type="bibr" rid="B37">Nazar et al., 2018</xref>; <xref ref-type="bibr" rid="B53">Siddique et al., 2021b</xref>). The particle size distribution of MTX-free &#xb5;E-B (&#x223c;55 nm), MTX-loaded &#xb5;E-B (&#x223c;70.5 nm), MTX-free &#xb5;E-C (&#x223c;57.5 nm), and MTX-loaded &#xb5;E-C (&#x223c;72 nm) is given in <xref ref-type="sec" rid="s10">Supplementary Material</xref> (<xref ref-type="sec" rid="s10">Supplementary Figure S4A, B</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>
<bold>(A)</bold> Size distribution of MTX-free &#xb5;E-A and MTX-loaded &#xb5;E-A. <bold>(B)</bold> FTIR spectrum of pure MTX. <bold>(C)</bold> FTIR spectra of the MTX-free &#xb5;E and MTX-loaded &#xb5;E.</p>
</caption>
<graphic xlink:href="fmats-11-1409310-g005.tif"/>
</fig>
<p>Zeta (&#x3b6;) potential is the most significant parameter to evaluate the stability of colloidal systems. A higher value of &#x3b6;-potential indicates higher stability without any aggregation of droplets, while a low zeta potential shows less stability, leading to aggregation or coagulation. A highly stable colloidal system shows a &#x3b6;-potential value of &#x3e;30 mV or &#x3c; -30 mV due to the steric and electrostatic repulsion between particles (<xref ref-type="bibr" rid="B32">Nazar et al., 2009</xref>; <xref ref-type="bibr" rid="B37">Nazar et al., 2018</xref>). These &#x3b6;-potential calculations show the stability of MTX-loaded &#xb5;E-A (&#x2212;36.95 mV), MTX-loaded &#xb5;E-B (&#x2212;28.6 mV), and MTX-loaded &#xb5;E-C (&#x2212;36.8 mV) in <xref ref-type="sec" rid="s10">Supplementary Material</xref> (<xref ref-type="sec" rid="s10">Supplementary Figure S5</xref>). The substantial negative &#x3b6;-potential values of nanodroplets in &#xb5;E systems are very suitable for the development of a stable drug delivery system. Additionally, the higher negative &#x3b6;-potential value demonstrated the improved stability and longer shelf life of the &#xb5;E system (<xref ref-type="bibr" rid="B8">Bhagyaraj and Krupa, 2020</xref>; <xref ref-type="bibr" rid="B50">Saleem et al., 2020</xref>; <xref ref-type="bibr" rid="B14">Freidus et al., 2021</xref>).</p>
</sec>
<sec id="s3-5">
<title>FTIR analysis</title>
<p>FTIR is a powerful analytical technique that provides information about the molecular structure and functional groups present in a sample. FTIR analysis was used to investigate possible interactions between MTX and the different components of the &#xb5;E system (<xref ref-type="bibr" rid="B5">Baptista and Tran, 1997</xref>; <xref ref-type="bibr" rid="B11">Dinache et al., 2020</xref>). The investigation concentrated on finding characteristic infrared peaks and patterns, which can show any alterations or shifts indicating chemical interactions in any &#xb5;E system before and after loading MTX. In order to guarantee the durability and efficacy of the &#xb5;E system as a drug delivery mechanism, this procedure is essential (<xref ref-type="bibr" rid="B32">Nazar et al., 2009</xref>).</p>
<p>The chemical stability of MTX in &#xb5;E systems and the interactions between MTX and the other components of &#xb5;Es were evaluated. As shown in <xref ref-type="fig" rid="F5">Figure 5B</xref>, the FTIR of MTX showed the following characteristic peaks: a major peak at 3,361 cm<sup>-1</sup> was observed due to the carboxylic group [O-H stretching], whereas the peak at 2,949 cm<sup>-1</sup> is assigned to the CH<sub>3</sub> group [C-H stretching]. The peaks at 1,639 cm<sup>-1</sup> were due to the stretching of the carbonyl group [C&#x3d;O stretching] and aromatic rings [C&#x3d;C stretching]. These spectroscopic studies of &#xb5;E-A, &#xb5;E-B, and &#xb5;E-C, together with MTX-free and MTX-loaded &#xb5;Es, are shown in <xref ref-type="fig" rid="F5">Figure 5C</xref> and <xref ref-type="sec" rid="s10">Supplementary Figure S4C, D</xref> in <xref ref-type="sec" rid="s10">Supplementary Material</xref>, respectively. The MTX-loaded &#xb5;E-A, &#xb5;E-B, and &#xb5;E-C showed that MTX was completely dissolved in optimal &#xb5;E systems without any aggregation and absence of any additional peak. Hence, there were no observable interactions present between MTX and &#xb5;E components, which confirms the chemical stability of MTX in the microstructure of the &#xb5;E systems (<xref ref-type="bibr" rid="B46">Rajinikanth et al., 2007</xref>).</p>
</sec>
<sec id="s3-6">
<title>Morphological analysis</title>
<p>The TEM micrographs shown in <xref ref-type="fig" rid="F6">Figure 6</xref> offer a detailed view of the high-resolution morphology of both the MTX-free &#x3bc;E and MTX-loaded &#x3bc;E. These images confirm a monomodal size distribution consistent with the estimations from DLS studies. Importantly, they reveal a notable increase in the size of the MTX-loaded &#x3bc;E compared to the MTX-free &#x3bc;E, indicating successful MTX loading. The micrographs of the MTX-free &#x3bc;E depict spherical surfaces with fine distribution, suggesting minimal alteration in morphology across all nano-colloidal dispersions. However, the increase in size observed implies the effective encapsulation of MTX, facilitating enhanced bioavailability and solubility. Specifically, &#x3bc;Es are utilized to encapsulate drugs with poor solubility and limited absorption capacity. The formation of these aggregates relies on self-assembly structures or patterns that navigate various obstacles to reach specific destinations, enabling controlled drug release at targeted sites (<xref ref-type="bibr" rid="B2">Alswieleh et al., 2020</xref>; <xref ref-type="bibr" rid="B18">Hanafy et al., 2023</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>TEM micrographs of the <bold>(A)</bold> MTX-free &#xb5;E and <bold>(B)</bold> MTX-loaded &#xb5;E.</p>
</caption>
<graphic xlink:href="fmats-11-1409310-g006.tif"/>
</fig>
<sec id="s3-6-1">
<title>Fluorescence spectral studies</title>
<p>One commonly used probing method to evaluate drug partitioning in the microdomains of &#xb5;Es is steady-state spectrofluorophotometry because the absorption properties of the drug are highly influenced by the polarity of the surrounding medium (<xref ref-type="bibr" rid="B25">Lissi et al., 2000</xref>; <xref ref-type="bibr" rid="B7">Bermejo et al., 2003</xref>; <xref ref-type="bibr" rid="B41">Pal et al., 2011</xref>). <xref ref-type="fig" rid="F7">Figure 7</xref> shows the maximum emissions (&#x3bb;<sub>em</sub>) of MTX at 365 nm (a characteristic of MTX) in the aqueous phase and appears at 435 nm in the oil phase. However, &#x3bb;<sub>em</sub> of MTX in S<sub>mix</sub>-A and &#xb5;E-A was located at 440 nm and 445 nm, respectively. In addition, the &#x3bb;<sub>em</sub> values of MTX in S<sub>mix</sub>-B, &#xb5;E-B, S<sub>mix</sub>-C, and &#xb5;E-C were observed at 405 nm, 415 nm, 438 nm, and 442 nm, respectively. &#x3bb;<sub>em</sub> of S<sub>mix</sub> and &#xb5;E systems showed a red shift in the wavelength with respect to the &#x3bb;<sub>em</sub> value of the aqueous phase. The &#x3bb;<sub>em</sub> values of the &#xb5;E systems are consistent with the &#x3bb;<sub>em</sub> values of the oil phase. The results suggested that the MTX molecules firmly partitioned themselves in the hydrophobic part of the &#xb5;Es, which indicates that a higher concentration of MTX is present in the non-polar microenvironment of the &#xb5;E systems and shielded by the aqueous domain (<xref ref-type="bibr" rid="B20">Ibrahim et al., 2010</xref>; <xref ref-type="bibr" rid="B41">Pal et al., 2011</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Fluorescence emission spectra of MTX in water, castor oil, S<sub>mix</sub>-A, S<sub>mix</sub>-B, S<sub>mix</sub>-C, and the optimal &#xb5;E-A, &#xb5;E-B, and &#xb5;E-C.</p>
</caption>
<graphic xlink:href="fmats-11-1409310-g007.tif"/>
</fig>
</sec>
<sec id="s3-6-2">
<title>Dissolution release profile studies</title>
<p>A comparative enhanced dissolution release profile of MTX-NPs obtained from all three &#x3bc;E systems was evaluated in different vessels. The results indicate that the drug release profile showed variations compared to conventional formulations at different sampling points in all three &#x3bc;E systems. <xref ref-type="fig" rid="F8">Figure 8</xref> shows that the average result found was 98.5% &#xb1; 1% (<italic>p</italic> &#x3c; 0.004) for MTX-NP-&#x3bc;E-A, 84.9% &#xb1; 3% (<italic>p</italic> &#x3c; 0.001) for MTX-NP-&#x3bc;E-B, and 80.3% &#xb1; 2.2% (<italic>p</italic> &#x3c; 0.005) for MTX-NP-&#x3bc;E-C.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Comparative release profile of MTX-NPs obtained from &#xb5;E-A, &#xb5;E-B, and &#xb5;E-C.</p>
</caption>
<graphic xlink:href="fmats-11-1409310-g008.tif"/>
</fig>
<p>MTX showed the maximum release in MTX-NP-&#x3bc;E-A compared to other formulations, which confirmed improved drug solubility and maximum bioavailability at the site of action (a complete datasheet of the comparative dissolution release profile is shown in <xref ref-type="sec" rid="s10">Supplementary Material</xref> <xref ref-type="sec" rid="s10">Supplementary Tables S1&#x2013;S3</xref>). The decreasing particle size at interfacial surfaces to the nanometer extent highly influenced the solubility, providing a high surface area for the encapsulation and dissolution rate of drugs with poor wettability (<xref ref-type="bibr" rid="B51">Saleem et al., 2019</xref>; <xref ref-type="bibr" rid="B50">Saleem et al., 2020</xref>). The release profile of MTX-NPs was compared with that of MTX-CF in different pH media at various intervals of time. MTX-NPs showed maximum release in all mediums with different pH values compared to MTX-CFs. However, the maximum release of MTX-NPs was &#x223c;80.4 &#xb1; 1.1% in the interlude of the first 5 min at pH 6.8, while it was &#x223c;75.3 &#xb1; 1.2% and &#x223c;65.4 &#xb1; 1.1% at a higher pH<italic>.</italic> Conclusively, MTX-NPs release MTX more readily at lower acidic pH and less so at higher pH, which indicated that the MTX-NPs were pH-sensitive, possibly due to their increased solubility under acidic conditions. This behavior suggests that the MTX might be more effective or stable under acidic conditions and can influence its formulation and therapeutic application. For instance, if intended for release in specific parts of the body like the stomach or intestines, the formulation might need adjustment to optimize release and efficacy. Understanding this pH-dependent release can also guide regulatory and clinical strategies, ensuring the MTX performs effectively under physiological conditions. The release profiles of both MTX-NPs and MTX-CFs at different pH values are given in <xref ref-type="sec" rid="s10">Supplementary Material</xref> <xref ref-type="sec" rid="s10">Supplementary Figures S6&#x2013;S9</xref>. The nanometrically dispersed MTX-NPs obtained from this study, with improved bioavailability, showed many remarkable advantages and features over other conventional formulations (<xref ref-type="bibr" rid="B30">Narayani and Rao, 1994</xref>; <xref ref-type="bibr" rid="B34">Nazar et al., 2011b</xref>; <xref ref-type="bibr" rid="B10">Church et al., 2018</xref>). Moreover, the MTX-NPs prepared from optimal &#x3bc;E systems can be used as a promising and efficient platform for improving the oral absorption and bioavailability of hydrophobic drugs.</p>
</sec>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>Conclusion</title>
<p>The results of the present study indicate the formation of MTX-NPs from three new &#x3bc;E formulations comprising Tween-60, castor oil, and water, while ethanol, 2-propanol, and 1-butanol are added as co-surfactants in each formulation. Electrical conductivity and viscosity data revealed the microstructural transition of the o/w &#x3bc;E to w/o &#x3bc;E via a bicontinuous region. Optical micrographs are also consistent with electrical conductance and viscosity data and verify the transition of phases in the &#x3bc;E system. The enhanced solubility of MTX in each optimized &#x3bc;E formulation is achieved, i.e., 3.5 wt% at pH 6.5, 4.8 wt% at pH 6.9, and 4.2 wt% at pH 6.3 in &#x3bc;E-A, &#x3bc;E-B, and &#x3bc;E-C, respectively. Furthermore, a high percentage of EE% and an excessive LE% were obtained for each formulation. The quantitative EE% and LE% are 94.22% &#xb1; 0.48% and 22.50% &#xb1; 0.48 for &#x3bc;E-A, 86.78% &#xb1; 0.92% and 17.75% &#xb1; 0.48 for &#x3bc;E-B, and 82.45% &#xb1; 1.15% and 15.95% &#xb1; 0.48 for &#x3bc;E-C, respectively. The DLS results show the monomodal size distribution (40&#x2013;72 nm) of droplets in &#x3bc;E systems without any aggregation or coalescence upon loading of anticancer MTX. FTIR spectroscopy revealed the good compatibility of anticancer MTX with &#x3bc;E excipients, and no observable molecular interaction was present between the excipients and &#x3bc;E. The probing dynamics results illustrate that more MTX was present in the hydrophobic region of the &#x3bc;E interface. Distinctly, the MTX-NPs obtained from the &#x3bc;E-A system offer superior oral bioavailability and maximum dissolution release (98.5 %&#xb1; 1%) values compared to the MTX-NPs from the &#x3bc;E-B (84.9% &#xb1; 3%) and &#x3bc;E-C (80.3% &#xb1; 2.2%) systems. It also confirms that better efficacy of the dosed drug will be achieved due to the higher bioavailability of the drug at the site of action. Moreover, the MTX-NPs prepared from optimal &#x3bc;E systems can be used as a promising and efficient platform for improving the oral absorption of hydrophobic drugs by investigating and determining the other possible intrinsic mechanisms.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>; further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>MS: formal analysis and writing&#x2013;original draft. SZ: software and writing&#x2013;review and editing. LR: methodology and writing&#x2013;original draft. MS: data curation, formal analysis, and writing&#x2013;review and editing. SH: writing&#x2013;review and editing, funding acquisition, methodology, and project administration. WA: writing&#x2013;review and editing and resources. KA: writing&#x2013;review and editing, investigation, and visualization. YI: writing&#x2013;review and editing and validation. SS: writing&#x2013;review and editing and formal analysis. MN: writing&#x2013;review and editing, conceptualization, and supervision.</p>
</sec>
<sec sec-type="funding-information" id="s7">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The research work was supported by Researchers supporting project number (RSP2024R399), King Saud University, Riyadh, Saudi Arabia.</p>
</sec>
<ack>
<p>The author, MN, acknowledges the Higher Education Commission of Pakistan for providing financial support through NRPU Project No. 20-17321/NRPU/R&#x26;D/HEC/2021. The authors sincerely appreciate funding from Researchers Supporting Project number (RSP2024R399) , King Saud University, Riyadh, Saudi Arabia. Furthermore, the authors acknowledge the Department of Chemistry, University of Education, Multan Campus, Pakistan, for providing laboratory facilities to conduct their research.</p>
</ack>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>WA was employed by Lahore Chemical &#x26; Pharmaceutical Works (Private) Limited.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmats.2024.1409310/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmats.2024.1409310/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acosta</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kurlat</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bisceglia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ginzberg</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baikauskas</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>S. J. C.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Induced electric birefringence and viscosity studies in microemulsions</article-title>. <source>Colloids Surfaces A</source> <volume>106</volume> (<issue>1</issue>), <fpage>11</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/0927-7757(95)03333-5</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alswieleh</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Beagan</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Alsheheri</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Alotaibi</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Alharthi</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Almeataq</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Hybrid mesoporous silica nanoparticles grafted with 2-(tert-butylamino) ethyl methacrylate-b-poly (ethylene glycol) methyl ether methacrylate diblock brushes as drug nanocarrier</article-title>. <source>Molecules</source> <volume>25</volume> (<issue>1</issue>), <fpage>195</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25010195</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amarji</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Katare</surname>
<given-names>O. P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics</article-title>. <source>J. drug Target.</source> <volume>24</volume> (<issue>2</issue>), <fpage>147</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.3109/1061186x.2015.1058804</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azfaralariff</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fazial</surname>
<given-names>F. F.</given-names>
</name>
<name>
<surname>Sontanosamy</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Lazim</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Food-grade particle stabilized pickering emulsion using modified sago (Metroxylon sagu) starch nanocrystal</article-title>. <source>J. Food Eng.</source> <volume>280</volume>, <fpage>109974</fpage>. <pub-id pub-id-type="doi">10.1016/j.jfoodeng.2020.109974</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baptista</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>C. D.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Electrical conductivity, near-infrared absorption, and thermal lens spectroscopic studies of percolation of microemulsions</article-title>. <source>J. Phys. Chem. B</source> <volume>101</volume> (<issue>21</issue>), <fpage>4209</fpage>&#x2013;<lpage>4217</lpage>. <pub-id pub-id-type="doi">10.1021/jp970017c</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrios</surname>
<given-names>C. H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Global challenges in breast cancer detection and treatment</article-title>. <source>Breast</source> <volume>62</volume>, <fpage>S3</fpage>&#x2013;<lpage>S6</lpage>. <pub-id pub-id-type="doi">10.1016/s0960-9776(21)00048-5</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bermejo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tobaruela</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Talavera</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Orte</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alvarez-Pez</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Fluorescent behavior of B-phycoerythrin in microemulsions of aerosol OT/water/isooctane</article-title>. <source>J. Colloid Interface Sci.</source> <volume>263</volume> (<issue>2</issue>), <fpage>616</fpage>&#x2013;<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9797(03)00391-6</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhagyaraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Krupa</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Alginate-mediated synthesis of hetero-shaped silver nanoparticles and their hydrogen peroxide sensing ability</article-title>. <source>Molecules</source> <volume>25</volume> (<issue>3</issue>), <fpage>435</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25030435</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Changez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Anwar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Alrahbi</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Olive oil-based reverse microemulsion for stability and topical delivery of methotrexate: <italic>in vitro</italic>
</article-title>. <source>ACS Omega</source> <volume>9</volume>, <fpage>7012</fpage>&#x2013;<lpage>7021</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.3c08875</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Church</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Bernin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Garcia-Bennett</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Hedin</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Dispersed uniform nanoparticles from a macroscopic organosilica powder</article-title>. <source>Langmuir</source> <volume>34</volume> (<issue>6</issue>), <fpage>2274</fpage>&#x2013;<lpage>2281</lpage>. <pub-id pub-id-type="doi">10.1021/acs.langmuir.7b03705</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinache</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tozar</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Smarandache</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Andrei</surname>
<given-names>I. R.</given-names>
</name>
<name>
<surname>Nistorescu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nastasa</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Spectroscopic characterization of emulsions generated with a new laser-assisted device</article-title>. <source>Molecules</source> <volume>25</volume> (<issue>7</issue>), <fpage>1729</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25071729</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Essa</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>El-Kemary</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Ebrahem Saied</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Leporatti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nemany Hanafy</surname>
<given-names>N. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Nano targeted therapies made of lipids and polymers have promising strategy for the treatment of lung cancer</article-title>. <source>Materials</source> <volume>13</volume>, <fpage>5397</fpage>. <pub-id pub-id-type="doi">10.3390/ma13235397</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Formariz</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Chiavacci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sarmento</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Franzini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Silva-</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scarpa</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Structural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidylcholine and their relationship with doxorubicin release</article-title>. <source>Colloids Surfaces B Biointerfaces</source> <volume>63</volume> (<issue>2</issue>), <fpage>287</fpage>&#x2013;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2007.12.021</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freidus</surname>
<given-names>L. G.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Marimuthu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pradeep</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Choonara</surname>
<given-names>Y. E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Theranostic mesoporous silica nanoparticles loaded with a curcumin-naphthoquinone conjugate for potential cancer intervention</article-title>. <source>Front. Mol. Biosci.</source> <volume>8</volume>, <fpage>670792</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2021.670792</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaudana</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ananthula</surname>
<given-names>H. K.</given-names>
</name>
<name>
<surname>Parenky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mitra</surname>
<given-names>A. K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Ocular drug delivery</article-title>. <source>AAPS J.</source> <volume>12</volume> (<issue>3</issue>), <fpage>348</fpage>&#x2013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1208/s12248-010-9183-3</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghazy</surname>
<given-names>M. G. M.</given-names>
</name>
<name>
<surname>Hanafy</surname>
<given-names>N. A. N.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Targeted therapies for breast and lung cancers by using Propolis loaded albumin protein nanoparticles</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>260</volume>, <fpage>129338</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.129338</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginsburg</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Bray</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Vanderpuye</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Eniu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kotha</surname>
<given-names>S. R.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>The global burden of women&#x2019;s cancers: a grand challenge in global health</article-title>. <source>Lancet</source> <volume>389</volume> (<issue>10071</issue>), <fpage>847</fpage>&#x2013;<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(16)31392-7</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanafy</surname>
<given-names>N. A. N.</given-names>
</name>
<name>
<surname>Sheashaa</surname>
<given-names>R. F.</given-names>
</name>
<name>
<surname>Moussa</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Mahfouz</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Potential of curcumin and niacin-loaded targeted chitosan coated liposomes to activate autophagy in hepatocellular carcinoma cells: an <italic>in vitro</italic> evaluation in HePG2 cell line</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>245</volume>, <fpage>125572</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.125572</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hegde</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Top 10 challenges in cancer immunotherapy</article-title>. <source>Immunity</source> <volume>52</volume> (<issue>1</issue>), <fpage>17</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2019.12.011</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibrahim</surname>
<given-names>H. K.</given-names>
</name>
<name>
<surname>El-Leithy</surname>
<given-names>I. S.</given-names>
</name>
<name>
<surname>Makky</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy</article-title>. <source>Mol. Pharm.</source> <volume>7</volume> (<issue>2</issue>), <fpage>576</fpage>&#x2013;<lpage>585</lpage>. <pub-id pub-id-type="doi">10.1021/mp900279c</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahlweit</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Busse</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Electric conductivity in microemulsions</article-title>. <source>J. Chem. Phys.</source> <volume>99</volume> (<issue>7</issue>), <fpage>5605</fpage>&#x2013;<lpage>5614</lpage>. <pub-id pub-id-type="doi">10.1063/1.465953</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Measuring size, size distribution, and polydispersity of water-in-oil microemulsion droplets using fluorescence correlation spectroscopy: comparison to dynamic light scattering</article-title>. <source>J. Phys. Chem. B</source> <volume>120</volume> (<issue>5</issue>), <fpage>1008</fpage>&#x2013;<lpage>1020</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jpcb.5b09920</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kizibash</surname>
<given-names>N. A.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Design of a microemulsion-based drug delivery system for diclofenac sodium</article-title>. <source>J. Chem. Soc. Pak.</source> <volume>33</volume> (<issue>6</issue>), <fpage>1</fpage>.</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawrence</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>G. D.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Microemulsion-based media as novel drug delivery systems</article-title>. <source>Adv. drug Deliv. Rev.</source> <volume>64</volume>, <fpage>175</fpage>&#x2013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2012.09.018</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lissi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Abuin</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Rubio</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Cer&#xf3;n</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Fluorescence of Prodan and Laurdan in AOT/heptane/water microemulsions: partitioning of the probes and characterization of microenvironments</article-title>. <source>Langmuir</source> <volume>16</volume> (<issue>1</issue>), <fpage>178</fpage>&#x2013;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1021/la990720n</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahdavinia</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Mosallanezhad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Soleymani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sabzi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Magnetic-and pH-responsive &#x3ba;-carrageenan/chitosan complexes for controlled release of methotrexate anticancer drug</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>97</volume>, <fpage>209</fpage>&#x2013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.01.012</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Drlica</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones</article-title>. <source>Mol. Microbiol.</source> <volume>61</volume> (<issue>3</issue>), <fpage>810</fpage>&#x2013;<lpage>825</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05275.x</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Ninham</surname>
<given-names>B. W.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Micelles, vesicles and microemulsions</article-title>. <source>J. Chem. Soc. Faraday Trans. 2 Mol. Chem. Phys.</source> <volume>77</volume> (<issue>4</issue>), <fpage>601</fpage>&#x2013;<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1039/f29817700601</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moshikur</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Wakabayashi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Moniruzzaman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Methotrexate-based ionic liquid as a potent anticancer drug for oral delivery: <italic>in vivo</italic> pharmacokinetics, biodistribution, and antitumor efficacy</article-title>. <source>Int. J. Pharm.</source> <volume>608</volume>, <fpage>121129</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2021.121129</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narayani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>K. P.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres</article-title>. <source>J. Microencapsul.</source> <volume>11</volume> (<issue>1</issue>), <fpage>69</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.3109/02652049409040439</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nazar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khosa</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2011a</year>). <article-title>Microemulsions in enhanced oil recovery: a review</article-title>. <source>Petroleum Sci. Technol.</source> <volume>29</volume> (<issue>13</issue>), <fpage>1353</fpage>&#x2013;<lpage>1365</lpage>. <pub-id pub-id-type="doi">10.1080/10916460903502514</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Microemulsion system with improved loading of piroxicam: a study of microstructure</article-title>. <source>AAPS PharmSciTech</source> <volume>10</volume> (<issue>4</issue>), <fpage>1286</fpage>. <pub-id pub-id-type="doi">10.1208/s12249-009-9328-9</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Mujeed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Siddique</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Zafar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saleem</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Structural dynamics of tween-based microemulsions for antimuscarinic drug mirabegron</article-title>. <source>Colloid Polym. Sci.</source> <volume>298</volume>, <fpage>263</fpage>&#x2013;<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1007/s00396-020-04603-w</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Myakonkaya</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Eastoe</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2011b</year>). <article-title>Separating nanoparticles from microemulsions</article-title>. <source>J. Colloid Interface Sci.</source> <volume>354</volume> (<issue>2</issue>), <fpage>624</fpage>&#x2013;<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcis.2010.11.017</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Saleem</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Bajwa</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Yameen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ashfaq</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zafar</surname>
<given-names>M. N.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Encapsulation of antibiotic levofloxacin in biocompatible microemulsion formulation: insights from microstructure analysis</article-title>. <source>J. Phys. Chem. B</source> <volume>121</volume> (<issue>2</issue>), <fpage>437</fpage>&#x2013;<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jpcb.6b09326</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Saleem</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Basharat</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nasrullah</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Asif</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ashfaq</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Architecting water-dispersible organic nanopowder from volatile microemulsion: an emerging colloidal technology</article-title>. <source>Colloid Interface Sci. Commun.</source> <volume>45</volume>, <fpage>100536</fpage>. <pub-id pub-id-type="doi">10.1016/j.colcom.2021.100536</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Yasir Siddique</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saleem</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Zafar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nawaz</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ashfaq</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Fourth-generation antibiotic gatifloxacin encapsulated by microemulsions: structural and probing dynamics</article-title>. <source>Langmuir</source> <volume>34</volume> (<issue>36</issue>), <fpage>10603</fpage>&#x2013;<lpage>10612</lpage>. <pub-id pub-id-type="doi">10.1021/acs.langmuir.8b01775</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O Dell</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>METHOTREXATE USE IN RHEUMATOID ARTHRITIS</article-title>. <source>Rheumatic Dis. Clin. N. Am.</source> <volume>23</volume> (<issue>4</issue>), <fpage>779</fpage>&#x2013;<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1016/s0889-857x(05)70360-4</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olivieri</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Seiller</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bromberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Besnard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Duong</surname>
<given-names>T. N. L.</given-names>
</name>
<name>
<surname>Grossiord</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Optimization of a thermally reversible W/O/W multiple emulsion for shear-induced drug release</article-title>. <source>J. Control. Release</source> <volume>88</volume> (<issue>3</issue>), <fpage>401</fpage>&#x2013;<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1016/s0168-3659(03)00013-0</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pal</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mandal</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Phase behavior, solubilization, and phase transition of a microemulsion system stabilized by a novel surfactant synthesized from castor oil</article-title>. <source>J. Chem. Eng. Data</source> <volume>62</volume> (<issue>4</issue>), <fpage>1278</fpage>&#x2013;<lpage>1291</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jced.6b00806</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pal</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Fluorescence correlation spectroscopy: an efficient tool for measuring size, size-distribution and polydispersity of microemulsion droplets in solution</article-title>. <source>Anal. Chem.</source> <volume>83</volume> (<issue>20</issue>), <fpage>7736</fpage>&#x2013;<lpage>7744</lpage>. <pub-id pub-id-type="doi">10.1021/ac2012637</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paria</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khilar</surname>
<given-names>K. C.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>A review on experimental studies of surfactant adsorption at the hydrophilic solid&#x2013;water interface</article-title>. <source>Adv. colloid interface Sci.</source> <volume>110</volume> (<issue>3</issue>), <fpage>75</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.cis.2004.03.001</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahdar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hajinezhad</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Nasri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Beyzaei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Barani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Trant</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The synthesis of methotrexate-loaded F127 microemulsions and their <italic>in vivo</italic> toxicity in a rat model</article-title>. <source>J. Mol. Liq.</source> <volume>313</volume>, <fpage>113449</fpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2020.113449</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Mollah</surname>
<given-names>M. Y. A.</given-names>
</name>
<name>
<surname>Susan</surname>
<given-names>M. A. B. H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Dynamic percolation and swollen behavior of nanodroplets in 1-ethyl-3-methylimidazolium trifluoromethanesulfonate/triton X-100/cyclohexane microemulsions</article-title>. <source>J. Phys. Chem. B</source> <volume>120</volume> (<issue>28</issue>), <fpage>6995</fpage>&#x2013;<lpage>7002</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jpcb.6b04763</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahman</surname>
<given-names>H. M. A. U.</given-names>
</name>
<name>
<surname>Afzal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Alvi</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Asghar</surname>
<given-names>M. N.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Phase behavior of a TX-100/oleic acid/water based ternary system: a microstructure study</article-title>. <source>J. Mol. Liq.</source> <volume>230</volume>, <fpage>15</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2017.01.011</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajinikanth</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Balasubramaniam</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Development and evaluation of a novel floating <italic>in situ</italic> gelling system of amoxicillin for eradication of <italic>Helicobacter pylori</italic>
</article-title>. <source>Int. J. Pharm.</source> <volume>335</volume> (<issue>1-2</issue>), <fpage>114</fpage>&#x2013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2006.11.008</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Joy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sa</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>pH dependent chemical stability and release of methotrexate from a novel nanoceramic carrier</article-title>. <source>RSC Adv.</source> <volume>5</volume> (<issue>49</issue>), <fpage>39482</fpage>&#x2013;<lpage>39494</lpage>. <pub-id pub-id-type="doi">10.1039/c5ra03546e</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Saleem</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). &#x201c;<article-title>Chapter 11 - self-nanoemulsifying drug delivery systems with bioavailability potential</article-title>,&#x201d; in <source>Novel platforms for drug delivery applications</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>P. P.</given-names>
</name>
</person-group> (<publisher-loc>Germany</publisher-loc>: <publisher-name>Woodhead Publishing</publisher-name>), <fpage>257</fpage>&#x2013;<lpage>275</lpage>.</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saleem</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Yameen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>S. Z.</given-names>
</name>
<name>
<surname>Khalid</surname>
<given-names>M. R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Structural insights into the microemulsion&#x2010;mediated formation of fluoroquinolone nanoantibiotics</article-title>. <source>ChemistrySelect</source> <volume>3</volume> (<issue>41</issue>), <fpage>11616</fpage>&#x2013;<lpage>11621</lpage>. <pub-id pub-id-type="doi">10.1002/slct.201801925</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saleem</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Yasir Siddique</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>S. U. D.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Formation of antihyperlipidemic nano-ezetimibe from volatile microemulsion template for enhanced dissolution profile</article-title>. <source>Langmuir</source> <volume>36</volume> (<issue>27</issue>), <fpage>7908</fpage>&#x2013;<lpage>7915</lpage>. <pub-id pub-id-type="doi">10.1021/acs.langmuir.0c01016</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saleem</surname>
<given-names>M. N. M.</given-names>
</name>
<name>
<surname>Siddique</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ashfaq</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>S. Z.</given-names>
</name>
<name>
<surname>Khalid</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Soft-templated fabrication of antihypertensive nano-Irbesartan: structural and dissolution evaluation</article-title>. <source>J. Mol. Liq.</source>, <fpage>292</fpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2019.111388</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siddique</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Alamgir</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Sumrra</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Ashfaq</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Safdar</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Structural and probing dynamics of Brij-35-based microemulsion for fluoroquinolone antibiotics</article-title>. <source>Colloid Polym. Sci.</source> <volume>299</volume> (<issue>9</issue>), <fpage>1479</fpage>&#x2013;<lpage>1488</lpage>. <pub-id pub-id-type="doi">10.1007/s00396-021-04871-0</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siddique</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Mahmood</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saleem</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Alwadai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Almuslem</surname>
<given-names>A. S.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Microemulsified gel formulations for topical delivery of clotrimazole: structural and <italic>in vitro</italic> evaluation</article-title>. <source>Langmuir</source> <volume>37</volume> (<issue>46</issue>), <fpage>13767</fpage>&#x2013;<lpage>13777</lpage>. <pub-id pub-id-type="doi">10.1021/acs.langmuir.1c02590</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siddique</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Saleem</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Haider</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sumrra</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>M. S.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Formulation of gelled microemulsion for effective permeation of celecoxib across the skin barrier</article-title>. <source>ChemistrySelect</source> <volume>9</volume> (<issue>3</issue>), <fpage>e202302841</fpage>. <pub-id pub-id-type="doi">10.1002/slct.202302841</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sultan Rana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nazeer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Abd El-Gawad</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Inam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>El-Bahy</surname>
<given-names>Z. M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Microemulsions as potential pesticidal carriers: a review</article-title>. <source>J. Mol. Liq.</source> <volume>390</volume>, <fpage>122969</fpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2023.122969</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ullah</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Alotaibi</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Formulation development and characterization of pH responsive polymeric nano-pharmaceuticals for targeted delivery of anti-cancer drug (methotrexate)</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>, <fpage>911771</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.911771</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xdc;st&#xfc;nda&#x11f;-Okur</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>G&#xf6;k&#xe7;e</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Bozb&#x131;y&#x131;k</surname>
<given-names>D. &#x130;.</given-names>
</name>
<name>
<surname>E&#x11f;rilmez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>&#xd6;zer</surname>
<given-names>&#xd6;.</given-names>
</name>
<name>
<surname>Ertan</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Preparation and <italic>in vitro</italic>&#x2013;<italic>in vivo</italic> evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis</article-title>. <source>Eur. J. Pharm. Sci.</source> <volume>63</volume>, <fpage>204</fpage>&#x2013;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejps.2014.07.013</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Jadhav</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kanase</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bodhe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dombe</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Preparation and evaluation of microemulsion containing antihypertensive drug</article-title>. <source>Int. J. Appl. Pharm.</source> <volume>10</volume> (<issue>5</issue>), <fpage>138</fpage>&#x2013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.22159/ijap.2018v10i5.27415</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zafar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nazar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Siddique</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Haider</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saleem</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Formulation and evaluation of ophthalmic microemulsion for enhanced topical administration of brinzolamide</article-title>. <source>Front. Mater.</source> <volume>11</volume>. <pub-id pub-id-type="doi">10.3389/fmats.2024.1363138</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zugazagoitia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guedes</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ponce</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ferrer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Molina-Pinelo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Paz-Ares</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Current challenges in cancer treatment</article-title>. <source>Clin. Ther.</source> <volume>38</volume> (<issue>7</issue>), <fpage>1551</fpage>&#x2013;<lpage>1566</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinthera.2016.03.026</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>